This inventor holds 1 USPTO granted patent and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Emiri Takaki: Innovator in Cancer Treatment
Introduction
Emiri Takaki is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for malignant tumors. Her innovative work has garnered attention in the scientific community.
Latest Patents
Emiri Takaki holds a patent for a compound known as 5-methyl-6-phenyl-4,5-dihydro-2H-pyridazin-3-one derivative. This invention provides an agent for treating malignant tumors, showcasing her commitment to advancing medical science. The compound is represented by a specific formula, which highlights its potential therapeutic applications.
Career Highlights
Emiri Takaki is associated with Otsuka Pharmaceutical Company, Limited, where she continues to work on groundbreaking research. Her career is marked by a dedication to improving patient outcomes through innovative drug development. With her expertise, she has become a valuable asset to her organization.
Collaborations
Emiri collaborates with talented colleagues, including Yuki Terauchi and Toshiyuki Hirose. These partnerships enhance her research efforts and contribute to the success of her projects.
Conclusion
Emiri Takaki's contributions to cancer treatment through her innovative patent reflect her dedication to improving healthcare. Her work at Otsuka Pharmaceutical Company, Limited, and collaborations with esteemed colleagues further underscore her impact in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile